Mechanisms, Biomarkers and Targets for Therapy in Alcohol-associated Liver Injury: From Genetics to Nutrition: Summary of the ISBRA 2018 Symposium.

[1]  Nitzan C Roth,et al.  Histopathology of Alcohol-Related Liver Diseases. , 2019, Clinics in liver disease.

[2]  A. Singal,et al.  Epidemiology of Alcohol Consumption and Societal Burden of Alcoholism and Alcoholic Liver Disease. , 2019, Clinics in liver disease.

[3]  M. Lucey.  Alcohol-Associated Cirrhosis. , 2019, Clinics in liver disease.

[4]  Themistoklis K. Kourkoumpetis,et al.  Pathogenesis of Alcoholic Liver Disease: An Update. , 2019, Clinics in liver disease.

[5]  C. McClain,et al.  Porphyromonas gingivalis as a Possible Risk Factor in the Development/Severity of Acute Alcoholic Hepatitis , 2018, Hepatology communications.

[6]  K. Kharbanda,et al.  Decreasing Phosphatidylcholine on the Surface of the Lipid Droplet Correlates with Altered Protein Binding and Steatosis , 2018, Cells.

[7]  T. Hendrikx,et al.  Antimicrobial proteins: intestinal guards to protect against liver disease , 2018, Journal of Gastroenterology.

[8]  Jeffrey B Warner,et al.  Ethanol and unsaturated dietary fat induce unique patterns of hepatic ω-6 and ω-3 PUFA oxylipins in a mouse model of alcoholic liver disease , 2018, PloS one.

[9]  H. Tilg,et al.  Paneth Cells and their Antimicrobials in Intestinal Immunity. , 2018, Current pharmaceutical design.

[10]  Alexander E. Lopez,et al.  A Protein‐Truncating HSD17B13 Variant and Protection from Chronic Liver Disease , 2018, The New England journal of medicine.

[11]  M. Raffatellu,et al.  G.I. pros: Antimicrobial defense in the gastrointestinal tract. , 2018, Seminars in cell & developmental biology.

[12]  C. McClain,et al.  Dietary Linoleic Acid and Its Oxidized Metabolites Exacerbate Liver Injury Caused by Ethanol via Induction of Hepatic Proinflammatory Response in Mice. , 2017, The American journal of pathology.

[13]  K. Kharbanda,et al.  Treatment options for alcoholic and non-alcoholic fatty liver disease: A review , 2017, World journal of gastroenterology.

[14]  R. Bataller,et al.  A prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis , 2017, Hepatology.

[15]  Hong-feng Jiang,et al.  Hydroxyeicosapentaenoic acids and epoxyeicosatetraenoic acids attenuate early occurrence of nonalcoholic fatty liver disease , 2017, British journal of pharmacology.

[16]  S. Popova,et al.  The relationship between different dimensions of alcohol use and the burden of disease—an update , 2017, Addiction.

[17]  Y. Takei,et al.  Pathogenesis of alcoholic liver disease , 2017, Hepatology research : the official journal of the Japan Society of Hepatology.

[18]  J. Clària,et al.  Pro-resolving mediators produced from EPA and DHA: Overview of the pathways involved and their mechanisms in metabolic syndrome and related liver diseases. , 2016, European journal of pharmacology.

[19]  C. McClain,et al.  Acrolein Is a Pathogenic Mediator of Alcoholic Liver Disease and the Scavenger Hydralazine Is Protective in Mice , 2016, Cellular and molecular gastroenterology and hepatology.

[20]  D. Gilroy,et al.  CYP450-derived oxylipins mediate inflammatory resolution , 2016, Proceedings of the National Academy of Sciences.

[21]  Dermot F. Reilly,et al.  The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent. , 2016, Gastroenterology.

[22]  R. Bataller,et al.  Pathogenesis and Management of Alcoholic Liver Disease , 2016, Digestive Diseases.

[23]  Ramon Bataller,et al.  Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia. , 2016, Gastroenterology.

[24]  R. Ahima,et al.  Pathophysiology of lipid droplet proteins in liver diseases. , 2016, Experimental cell research.

[25]  D. Mashek,et al.  Quantitative analysis of the murine lipid droplet-associated proteome during diet-induced hepatic steatosis[S] , 2015, Journal of Lipid Research.

[26]  K. Huse,et al.  A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis , 2015, Nature Genetics.

[27]  H. Aukema,et al.  Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs. , 2015, Advances in nutrition.

[28]  S. Caldwell,et al.  Lipid droplet-associated proteins in alcoholic liver disease: a potential linkage with hepatocellular damage. , 2015, International journal of clinical and experimental pathology.

[29]  Y. Kuo,et al.  PNPLA3 Gene Polymorphism Is Associated With Predisposition to and Severity of Alcoholic Liver Disease , 2015, The American Journal of Gastroenterology.

[30]  L. Listenberger,et al.  Surface features of the lipid droplet mediate perilipin 2 localization. , 2014, Biochemical and biophysical research communications.

[31]  A. Hamsten,et al.  TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content , 2014, Proceedings of the National Academy of Sciences.

[32]  Charles N. Serhan,et al.  Pro-resolving lipid mediators are leads for resolution physiology , 2014, Nature.

[33]  R. Ahima,et al.  Absence of Perilipin 2 Prevents Hepatic Steatosis, Glucose Intolerance and Ceramide Accumulation in Alcohol-Fed Mice , 2014, PloS one.

[34]  Anne Tybjærg-Hansen,et al.  Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease , 2014, Nature Genetics.

[35]  Robert V Farese,et al.  The biophysics and cell biology of lipid droplets , 2013, Nature Reviews Molecular Cell Biology.

[36]  F. Haj,et al.  Soluble Epoxide Hydrolase Deficiency or Inhibition Attenuates Diet-induced Endoplasmic Reticulum Stress in Liver and Adipose Tissue* , 2013, The Journal of Biological Chemistry.

[37]  J. Borén,et al.  Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro. , 2012, Journal of hepatology.

[38]  C. McClain,et al.  Acrolein cytotoxicity in hepatocytes involves endoplasmic reticulum stress, mitochondrial dysfunction and oxidative stress. , 2012, Toxicology and applied pharmacology.

[39]  G. Thallinger,et al.  Lipidomic analysis of lipid droplets from murine hepatocytes reveals distinct signatures for nutritional stress[S] , 2012, Journal of Lipid Research.

[40]  Robert V Farese,et al.  Lipid droplets and cellular lipid metabolism. , 2012, Annual review of biochemistry.

[41]  R. Ahima,et al.  Reduction of TIP47 improves hepatic steatosis and glucose homeostasis in mice. , 2012, American journal of physiology. Regulatory, integrative and comparative physiology.

[42]  C. McClain,et al.  Zinc and liver disease. , 2012, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[43]  K. Kharbanda,et al.  Betaine Treatment Attenuates Chronic Ethanol-Induced Hepatic Steatosis and Alterations to the Mitochondrial Respiratory Chain Proteome , 2011, International Journal of Hepatology.

[44]  Christian Gieger,et al.  Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma , 2011, Nature Genetics.

[45]  P. Saha,et al.  Absence of adipose differentiation related protein upregulates hepatic VLDL secretion, relieves hepatosteatosis, and improves whole body insulin resistance in leptin-deficient mice[S] , 2010, Journal of Lipid Research.

[46]  Ariel D. Quiroga,et al.  Altered Lipid Droplet Dynamics in Hepatocytes Lacking Triacylglycerol Hydrolase Expression , 2010, Molecular biology of the cell.

[47]  P. Haber,et al.  Patatin‐like phospholipase domain containing 3: A case in point linking genetic susceptibility for alcoholic and nonalcoholic liver disease , 2010, Hepatology.

[48]  V. Dolinsky,et al.  Loss of TGH/Ces3 in mice decreases blood lipids, improves glucose tolerance, and increases energy expenditure. , 2010, Cell metabolism.

[49]  B. Ward,et al.  Betaine administration corrects ethanol-induced defective VLDL secretion , 2009, Molecular and Cellular Biochemistry.

[50]  Alexander Pertsemlidis,et al.  Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease , 2008, Nature Genetics.

[51]  Charles N. Serhan,et al.  Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators , 2008, Nature Reviews Immunology.

[52]  D. Thompson,et al.  Dihydroxyoctadecamonoenoate esters inhibit the neutrophil respiratory burst , 2007, Journal of Biosciences.

[53]  Elysa B. Goldberg,et al.  Adipocyte differentiation‐related protein reduces lipid droplet association of adipose triglyceride lipase and slows triacylglycerol turnover , 2007, Journal of lipid research.

[54]  K. Kharbanda,et al.  Betaine attenuates alcoholic steatosis by restoring phosphatidylcholine generation via the phosphatidylethanolamine methyltransferase pathway. , 2007, Journal of hepatology.

[55]  K. Gaus,et al.  Identification and Characterization of Associated with Lipid Droplet Protein 1: A Novel Membrane‐Associated Protein That Resides on Hepatic Lipid Droplets , 2006, Traffic.

[56]  F. Stickel,et al.  The role of genetic polymorphisms in alcoholic liver disease. , 2006, Alcohol and alcoholism.

[57]  Christopher J. Chang,et al.  Zinc-secreting Paneth Cells Studied by ZP Fluorescence , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[58]  Y. Higashi,et al.  Identification of major proteins in the lipid droplet-enriched fraction isolated from the human hepatocyte cell line HuH7. , 2004, Biochimica et biophysica acta.

[59]  K. Kharbanda,et al.  Betaine lowers elevated s-adenosylhomocysteine levels in hepatocytes from ethanol-fed rats. , 2003, The Journal of nutrition.

[60]  D. Vance,et al.  The FASEB Journal express article 10.1096/fj.02-0728fje. Published online July 18, 2003. Inhibitors of hepatic microsomal triacylglycerol hydrolase decrease very low density lipoprotein secretion , 2022 .

[61]  G. Cortopassi,et al.  Cellular characterization of leukotoxin diol-induced mitochondrial dysfunction. , 2001, Archives of biochemistry and biophysics.

[62]  B. Hammock,et al.  Toxicity of epoxy fatty acids and related compounds to cells expressing human soluble epoxide hydrolase. , 2000, Chemical research in toxicology.

[63]  N. Weintraub,et al.  Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation. , 1998, Circulation research.

[64]  A. Salter,et al.  The intracellular triacylglycerol/fatty acid cycle: a comparison of its activity in hepatocytes which secrete exclusively apolipoprotein (apo) B100 very-low-density lipoprotein (VLDL) and in those which secrete predominantly apoB48 VLDL. , 1998, The Biochemical journal.

[65]  B. Borhan,et al.  Novel metabolic pathways for linoleic and arachidonic acid metabolism. , 1996, Biochimica et biophysica acta.

[66]  G. Gibbons,et al.  The lipolysis/esterification cycle of hepatic triacylglycerol. Its role in the secretion of very-low-density lipoprotein and its response to hormones and sulphonylureas. , 1992, The Biochemical journal.

[67]  G. Omenn,et al.  Evidence of genetic predisposition to alcoholic cirrhosis and psychosis: twin concordances for alcoholism and its biological end points by zygosity among male veterans. , 1981, Alcoholism, clinical and experimental research.

[68]  K. Kharbanda,et al.  Alcoholic Liver Disease: Pathogenesis and Current Management , 2017, Alcohol research : current reviews.

[69]  C. McClain,et al.  Medical Management of Severe Alcoholic Hepatitis: Expert Review from the Clinical Practice Updates Committee of the AGA Institute , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[70]  David Kershenobich,et al.  Variant in PNPLA3 is associated with alcoholic liver disease , 2010, Nature Genetics.

[71]  J. Falck,et al.  14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha. , 2006, American journal of physiology. Heart and circulatory physiology.

[72]  R. Pease,et al.  The roles of insulin and fatty acids in the regulation of hepatic very-low-density lipoprotein assembly. , 2002, Journal of the Royal Society of Medicine.